We previously reported that a host protein, f12 microglobulin (fl2m) inhibited the detection of human cytomegalovirus (CMV) in urine specimens by enzyme immunoassay and postulated that fl2m bound to the virus particle and masked the viral antigenic determinants. We report here that CMV strain AD169 grown in cell culture bound human fl2m when this protein was added to cell culture fluids or when the virus was added to urine. Such binding was not seen with herpes simplex virus. CMV could also bind bovine fl2m from foetal calf serum in cell culture fluids. The use of radiolabelled flzm in other experiments showed that CMV bound fl2m after release from cells and that the bound fl2m did not represent acquisition of class I HLA molecules during budding from host cell membranes. Immunoprecipitation studies showed that fl2m was bound by two viral envelope proteins fl2m BP1 (fl2m-binding protein 1) and fl2m BP2 of molecular masses 36 000 and 65 000 daltons respectively, fl2m
INTRODUCTION
Infection with human cytomegalovirus (CMV) is widespread and is usually associated with asymptomatic illness or occasionally a mononucleosis-like syndrome (Weller, 1971) . However, CMV is a major cause of morbidity and mortality in immunocompromised individuals such as recipients of renal or bone marrow transplants (Ho, 1977) or patients with the aquired immunodeficiency syndrome (Sonnabend et al., 1983) . The foetus is also at high risk from congenital CMV infection which occurs in 0.3 ~ to 2~ of all neonates with approximately 20~ of those infected developing disease during childhood (Stagno et al., 1983) .
Diagnosis of CMV relies on culture of the virus from clinical specimens, as serology is unreliable in immunocompromised patients and is fraught with difficulties in the newborn (Griffiths, 1984) . However, isolation of CMV in cell culture is both labour-intensive and slow, with c.p.e, often not becoming apparent until the second or third'week after inoculation. We have previously developed an antigen capture enzyme-linked immunosorbent assay (ELISA) using virus-specific monoclonal antibodies which could rapidly detect CMV in cell culture supernatants, but unfortunately this assay failed to detect the virus in fresh urine specimens (McKeating et al., 1985) . We have reported the identification of a urinary protein, fiE microglobulin (fl2m), which at physiological concentrations inhibited the ELISA detection of cell culture-grown CMV (McKeating et al., 1986) . fl2m caused inhibition only when added to the virus preparation and not when added to the antibody bound to the solid phase. We postulated that fl2m prevented the detection of cell culture-grown CMV by ELISA by binding to the virus and masking its antigenic determinants and predicted that in vivo, in urine, flEm was bound to CMV in a similar manner.
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To test this hypothesis we have examined whether CMV propagated in cell cultures has the capacity to bind fl2m. In an accompanying paper (McKeating et al., 1987) we have investigated whether fl2m is bound to CMV as it is found naturally in body fluids.
METHODS
Cellcultures. Human foreskin fibroblasts were maintained at 37 °C in Eagle's MEM (Gibco) supplemented with 3~ foetal calf serum (FCS) (Flow Laboratories). In some experiments the cells were cultured in serum-free medium supplemented with a serum substitute, 2% Ultroser G (LKB). In the latter case cells were passaged at least ten times in the serum-free medium before being used in experiments. Purified human fl2m (Serotec) was added to the culture medium at 2 gg/ml in certain experiments as indicated.
Production and purification of cell culture-grown CMV and herpes simplex virus (HSV) . Confluent fibroblast monolayers were infected with CMV strain AD169 and the culture supernatant was harvested when c.p.e. involved 80 to 90~ of the ceils. This extracellular virus was purified by ultracentrifugation through potassium tartrate/glycerol positive density/negative viscosity gradients (Talbot & Almeida, 1977) at 400000g for 45 rain. Two bands were visible; one, a distinct band containing membranous material, was discarded and the other, diffuse band representing the virions, was collected.
Intracellular virus was harvested by scraping off the cells, freezing and thawing three times, followed by ultrasonic disruption (two bursts of 30 s in an ultrasonic water bath). After clarification at 1500g for 30 min, intracellular virus was gradient-purified as described above.
In one experiment HSV type I was harvested and purified from cell culture fluids in an identical manner to that described for CMV strain AD169.
Labelling with radioiodide in vitro. Purified virions resuspended in phosphate-buffered saline (PBS) were labelled with t2sI using the iodogen method (Fraker & Speck, 1978) . Unincorporated isotope was removed by ultrafiltration (Amicon G25 ultrafiltration cones).
Purified human fl2m was iodinated with iodogen and unincorporated isotope was removed by gel filtration through Sephadex G-50 (Pharmacia). The radiolabelled flzm (sp. act. 1 mBq/~tg) was added to serum-free medium at 105 c.p.m./ml.
PAGE. Viral proteins were separated by electrophoresis in an 8 to 12~ or a 9 to 16~ gradient polyacrylamide gel in the presence of 0.1~ SDS (Laemmli, 1970) . Pre-stained molecular mass markers (Bethesda Research Laboratories) were used. Protein bands were visualized by staining with Coomassie Brilliant Blue.
Western blotting. Proteins separated by SDS-PAGE were electrophoretically transferred to nitrocellulose membranes using 25 mM-Tris-HC1, 192 mM-glycine pH 8-3 with 20~ methanol (Towbin et at., 1979) . Protein bands were visualized by staining with amido black (Towbin et al., 1979) . Non-specific protein binding sites were blocked by treating the filters with 2~ rabbit serum, 3~ bovine serum albumin (BSA), 0-2~ Tween 20, 0.02~ sodium azide in PBS (Buffer A) for 3 h at 4 °C. The membranes were incubated with 5 ml of monoclonal antibody specific for human fl2m (C21, kind gift from Dr A. Sanderson) diluted 1/500 in Buffer A, for 12 h at 4 °C. After four washes in 50 mM-Tris-HC1, 0"9% (w/v) NaCI, 1 mM-EDTA, 0.25 % BSA, 0-05~ Tween 20, pH 7.4 (Buffer B), the membranes were treated with 125I-labelled sheep anti-mouse immunoglobin (Amersham) at 105 c.p.m./ml in Buffer A for 12 h at 4 °C. Unbound antibody was removed by repeated washing with Buffer B, followed by drying and autoradiography.
Avidin-biotin detection of proteins present on nitrocellulose filters. The presence of CMV proteins in the fractions from glycerol-potassium tartrate gradients was detected after allowing 5 I11 of each fraction to dry onto nitrocellulose paper. The filter was quenched in Buffer A (as for Western transfer) at room temperature for 30 min, and washed in Tris-buffered saline (TBS) (0.01 M-Tris-HCI, 0" 15 M-NaCI, pH 7.5) four times. The filter was then incubated with a pool of CMV-specific monoclonal antibodies (CH33, CH45 and CH92) diluted 1/100 in Buffer A. at 37 °C for 2 h. The filters were washed four times in TBS and incubated with biotinylated anti-mouse immunoglobulin (Sigma) in Buffer A for 2 h at 37 °C. The filters were washed four times with TBS and incubated with horseradish peroxidase-avidin in Buffer A for 2 h at 37 °C. Finally, the filters were washed four times with TBS and incubated with diaminobenzidine (50 mg diaminobenzidine per 100 ml 0.05 M-Tris-HC1 pH 8.3 plus the addition prior to use of 0-167 ml 30 ~ H202) un il the colour reaction developed. The filters were then washed in distilled water and dried in air.
Solubilization of t251-1abelled CMV strain AD169 envelope. A preparation of radiolabelled CMV envelope glycoproteins was obtained by extraction of ~ 25I-labelled purified virions with 10 mM-Tris-HC1, 1 mM-CaCI, 0"15 ~-NaC1, 1% Triton X-100, 2 mi-phenylmethylsulphonyl fluoride, 1 ~ ethanol, at pH 7.3 and treatment with ultrasound (two bursts of 30 s at 0 °C) in an ultrasonic water bath (Farrar & Oram, 1984) . After 20 min at 0 °C the suspension was centrifuged for 10 min in a microcentrifuge (MSE). The supernatant containing the Triton-soluble material was collected.
Biotin conjugation of antibodies. Ammonium sulphate-precipitated antibodies in PBS were reacted in a 50 : 1 (v/v) ratio and a I : 5 (mole/mole) ratio of biotinyl-N-hydroxysuccinimide ester (Sigma) in dimethylformamide for 4 h at room temperature. The antibody mixture was then dialysed at 4 °C overnight against PBS to remove unconjugated material and stored at 4 °C in 0-05 ~ sodium azide. To check that the biotinylation of the antibodies was achieved they were titrated in an ELISA system with streptavidin-peroxidase and soluble diaminobenzidine substrate.
Immunoprecipitation ofradiolabelled envelope proteins. Solubilized envelope proteins containing 2 x 106 c.p.m.
were pre-absorbed with normal rabbit serum and normal mouse serum for 1 h with continuous rotation at 4 °C, and any non-specific immune complexes were collected by centrifugation in a microfuge (MSE) after the addition of Protein A-Sepharose (Pharmacia). The supernatants were then incubated with 1 ~tg of various biotinconjugated antibodies in 200 ~tl PBS with 1 ~ BSA for 2 h at room temperature with continuous rotation. Specific immune complexes were collected by the addition of 20pl streptavidin-agarose (Bethesda Research Laboratories), rotating for 1 h at room temperature, followed by microcentrifugation. Immunoprecipitates were washed in 0.05 i-Tris-HCl, 0.1 M-NaCI, 1 ~ Triton X-100, 0.1 ~ SDS at pH 7.3 three times, reducing the detergent concentration by 50~ in each subsequent wash.
Antibodies used were a polyclonal rabbit serum against fl2m (Unilever) and RF6, a mouse monoclonal antibody against hepatitis B surface antigen (Royal Free Hospital).
RESULTS
Acquisition of fl2m by CMV strain AD169 in vitro from cell culture fluids CMV strain AD169 was harvested from the culture fluid of virus-infected human foreskin fibroblasts grown in serum-free medium to which purified human fl2m had been added. The virus was gradient-purified and electrophoresed in an 8 to 12~ SDS-polyacrylamide gel. After Western transfer onto a nitrocellulose filter and amido black staining, a protein band was seen with a molecular mass of approximately 11000 to 12000 daltons (not shown).
The filters were probed with a mouse monoclonal antibody against human fl2m (C21) and bands were detected with 125I-labelled anti-mouse immunoglobulin. Autoradiography revealed a single band in this virus preparation in the same position as that seen when purified human flEm was run on the same gel (Fig. 1) . A fl2m band was not seen in the virus preparation from cells grown in serum-flee medium (Fig. 1) . Thus CMV grown in vitro can acquire human fl2m
when it is present in the cell culture fluid.
Binding of fl2m by CMV strain AD169 when added to urine
CMV strain AD 169 harvested from the cell culture supernatant of cells grown in the presence of FCS was added to normal urine from a CMV-seronegative individual or a Tris buffer of the same pH. The virus was gradient-purified and the presence of fl2m assessed by Western blotting as above. Fig. 2 shows that fl2m was detected by Western blotting using monoclonal antibodies specific for fl2m in the virus preparation which had been added to urine, but was absent from the purified virus preparation which had been incubated with Tris buffer.
Thus CMV strain AD169 from cell culture can acquire flz when added to urine. In contrast, HSV harvested from cell culture fluids failed to bind fl2m when added to urine in a similar manner (Fig. 2) .
CMV strain AD169 binds 125I-labelled flzm from cell culture fluids after release from cells
Human foreskin fibroblasts were grown in serum-free medium and, after adsorption of AD169 for 1 h, medium containing ~ zSI-labelled human fl2m was added. When extensive c.p.e. was observed, extracetlular and intracellular virus was harvested, unbound 125I-labelled flzm removed by ultrafiltration, and the virus preparations were gradient-purified. Fractions from the gradient were counted for radioactivity and analysed for the presence of CMV proteins by immunoblotting.
The intracellular virus formed a diffuse visible band on the gradient and had fractions containing viral proteins detectable by immunoblotting, but these fractions were not radiolabelled (Fig. 3) .
In the extracellular preparation the peaks of radioactivity coincided with the visible diffuse virus band and with the fractions containing viral proteins (Fig. 3) . Thus CMV had acquired the radiolabelled fl2m from the culture fluid, during or after release from cells. It is not clear whether Cells were grown in serum-free medium and after infection with AD169, 12Si.labelled/32m was added at l0 s c.p.m./ml. Intracellular (A) and extracellular (0) virus were purified on potassium tartrate/glycerol gradients and the radioactivity incorporated in each fraction is shown for the two virus preparations. The fractions containing the virus, as determined by immunoblotting using CMV-specific monoclonal antibodies, are shown (+).
Characterization of the viral proteins that bind flzm CMV strain AD 169 was harvested from the culture fluid of fibroblasts grown in the presence of FCS, gradient-purified and radiolabeUed with 12sI. The envelope proteins were extracted using Triton and immunoprecipitated with a polyclonal rabbit antibody specific for fl2m which recognized both bovine and human flzm. An irrelevant antibody specific for hepatitis B surface antigen was used as a control. The proteins present in the immunoprecipitate were separated by electrophoresis in an 9 to 16~ gradient SDS-polyacrylamide gel. Fig. 4 shows an autoradiograph of the separated proteins and it can be seen that the rabbit anti-fl2m antibody immunoprecipitated three radiolabelled envelope proteins of molecular masses 65, 36 and 11,7 kilodaltons, the latter corresponding to fl2m.
DISCUSSION
Our results show that CMV strain AD169 grown in vitro can acquire human fl2m when this protein is added to the cell culture medium. The presence of fl2m on purified virus particles was demonstrated by Western blotting and by the binding of radiolabeUed f12 m. Similarly, CMV strain AD169 harvested from cell culture fluids could bind human f12 m when added to urine, which normally contains this protein (Evrin & Wibell, 1972) . We have previously postulated that the inhibition of the capture of CMV strain AD169 using CMV-specific monoclonal antibodies induced by f12 m is due to the masking of the viral antigenic determinants of the virus by the binding of fl2m (McKeating et al., 1986) . Our demonstration that CMV strain AD169 exhibits a strong binding capacity for fl2m in vitro supports this hypothesis.
The use of radiolabelled human fl2m showed that only extracellular virus, and not intracellular virus, had acquired the labelled material, indicating that CMV strain AD169 binds fl2m during or after release from cells. All nucleated cells synthesize and express f12 m, which forms the light chain of class I HLA molecules. It is possible therefore that CMV acquired the labelled f12 m during the budding process as an integral part of the viral envelope, since it is well known that flzm in culture fluids can exchange with that on the cell surface (Ball et al., 1984; Kefford et al., 1984; Sanderson et al., 1985) . However, this explanation is unlikely since detectable amounts of fl2m were only found on virus harvested from cultures to which exogenous flzm had been added. Furthermore, virus harvested from cell culture fluids bound human fl2m when the virus was added to urine. Thus our results strongly suggest that the binding offl2m by CMV strain AD169 occurs after the virus is released from cells. We have shown that CMV strain AD169 can also bind radiolabelled purified bovine flzm when this substance is added to culture fluids (data not shown). Thus virus harvested from the fluid of cells grown in the presence of FCS has bovine fl2m bound to the viral particle. This was not demonstrated on the Western blot of such a virus preparation, shown in Fig. 2 (lane 1) , since the monoclonal antibody used for the detection does not recognize bovine f12 m under the reducing conditions employed. Furthermore the amount of bovine fl2m bound by the virus appears to be lower than that of human flzm. This conclusion is supported by the finding that virus grown in the presence of FCS could still bind additional human fl2m when added to urine (Fig. 2) 
